Shopping Cart
- Remove All
 Your shopping cart is currently empty Your shopping cart is currently empty
PAOPA is a novel dopamine D2 receptor modulator and L-proline-L-leucine-glycine amide (PLG) peptide mimetic that prevents and reverses behavioral and biochemical abnormalities in preclinical animal models of schizophrenia sensitized to amphetamine. PAOPA has been used in the study of schizophrenia and extrapyramidal dysfunction.

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 1 mg | $148 | In Stock | |
| 5 mg | $372 | In Stock | |
| 10 mg | $612 | In Stock | |
| 25 mg | $1,290 | In Stock | |
| 50 mg | $1,980 | In Stock | |
| 100 mg | $2,790 | In Stock | 
| Description | PAOPA is a novel dopamine D2 receptor modulator and L-proline-L-leucine-glycine amide (PLG) peptide mimetic that prevents and reverses behavioral and biochemical abnormalities in preclinical animal models of schizophrenia sensitized to amphetamine. PAOPA has been used in the study of schizophrenia and extrapyramidal dysfunction. | 
| In vitro | 10 μM PAOPA, treated for 1.5 hr increased striatal expression of GRK2 in D2/eYFP-labeled cells and promoted expression of arrestin-3, phosphorylated ERK1 and ERK2. 10 μM PAOPA, treated for 48 h then promoted internalization of D2 receptors in D2/eYFP-labeled cells. [1] | 
| In vivo | In chronic administration, intraperitoneal injection of 1 mg/kg PAOPA once daily for 45 days enhanced D2 receptor modulation and up-regulated the expression of downstream molecules (e.g., GRK2, arrestin-3, and phosphorylated ERK 1/2) in mice. [1] | 
| Molecular Weight | 254.29 | 
| Formula | C11H18N4O3 | 
| Cas No. | 114200-31-6 | 
| Smiles | N(C(=O)[C@@H]1CCCN1)[C@H]2C(=O)N(CC(N)=O)CC2 | 
| Relative Density. | 1.33 g/cm3 (Predicted) | 
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (176.96 mM), Sonication is recommended.   H2O: <25.43 mg/mL, Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
| Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
| DMSO 
 | ||||||||||||||||||||||||||||||||||||
 For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL .  A total of 10 animals were administered, and the formula you used is 5%
 A total of 10 animals were administered, and the formula you used is 5%  DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
 (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first. main solution, add 300 μLPEG300
 main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O
 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
 mix well and clarify
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.